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Abstract
Background: Intravenous thrombolytic therapy after ischaemic stroke significantly reduces mortality and morbidity.
Actual thrombolysis rates are disappointingly low in many western countries. It has been suggested that
higher patient volume is related to shorter door-to-needle-time (DNT) and increased thrombolysis rates. We
address a twofold research question: a) What are trends in national thrombolysis rates and door-to-needle
times in the Netherlands between 2005–2012? and b) Is there a relationship between stroke patient volume
per hospital, thrombolysis rates and DNT?
Methods: We used data from the Stroke Knowledge Network Netherlands dataset. Information on volume,
intravenous thrombolysis rates, and admission characteristics per hospital is acquired through yearly surveys,
in up to 65 hospitals between January 2005 and December 2012. We used linear regression to determine a
possible relationship between hospital stroke admission volume, hospital thrombolysis rates and mean hospital DNT,
adjusted for patient characteristics.
Results: Information on 121.887 stroke admissions was available, ranging from 7.393 admissions in 2005 to
24.067 admissions in 2012. Mean national thrombolysis rate increased from 6.4 % in 2005 to 14.6 % in 2012.
Patient characteristics (mean age, gender, type of stroke) remained stable. Mean DNT decreased from 72.7 min in
2005 to 41.4 min in 2012. Volume of stroke admissions was not an independent predictor for mean thrombolysis rate
nor for mean DNT.
Conclusion: Intravenous thrombolysis rates in the Netherlands more than doubled between 2005 and 2012, in parallel
with a large decline in mean DNT. We found no convincing evidence for a relationship between stroke patient volume
per hospital and thrombolysis rate or DNT.
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Background
Intravenous thrombolytic therapy (IVT) within 4,5 h after
onset of ischaemic stroke results in a significant reduction
in mortality and morbidity [1, 2]. If treatment delay is
avoided, up to 24 % of stroke patients may be eligible for
thrombolysis [3]. National data are mostly lacking, but
studies have reported disappointingly low thrombolysis
rates in many countries, e.g., United Kingdom (1,4 % in
2008) [4], Germany (8.4 in 2009) [5], Sweden (6,7 between
2007 and 2010) [6] and the USA (2,4 % in 2006) [7]. Re-
gional differences in IVT have been described with much
higher thrombolysis rates in some regions. E.g. in 15,7 % in
South London in [8] and up to 35 % in the German state of
Hesse in 2007–2008 [9]. In most countries, including the
Netherlands, actual thrombolysis numbers and trends in
national rates are unknown.
In various fields, especially in surgical specialties, a rela-
tionship between volume of treated patients and outcome
has been demonstrated [10, 11]. Directed by the Leapfrog
group, this finding has led to volume-based referral
strategies and the introduction of volume thresholds
in complex surgical interventions [12]. Some studies
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have suggested a positive relationship between volume
of stroke patients per center and outcome [13–15].
Other studies did not confirm this relationship [16, 17] or
questioned the actual meaning of the correlation, as a
volume-outcome effect does not identify the underlying
mechanisms through which higher case volume can
translate into better outcomes [18, 19]. One possible
mechanism through which high volumes may result
in better outcomes is the improvement of logistic
processes, which may reduce treatment delay and in-
crease thrombolysis rates.
As the debate for stroke care is on-going, we aimed to
assess the relationship between stroke patient volume,
thrombolysis rates and DNT in a national stroke regis-
try. We address a twofold research question: a) What
are trends in national thrombolysis rates and door-to-
needle times in the Netherlands between 2005–2012?
and b) Is there a relationship between stroke admission
volume per hospital, thrombolysis rates and DNT?
Methods
Study population
We used data on stroke admissions from the Knowledge
Network Stroke Netherlands (KNSN) dataset. The sci-
entific advisory board of the KNSN registration per-
mitted of the analysis. Anonymised data sets are
available for scientific research and can be obtained
after approval by the scientific advisory board. KNSN
foundation was set up in 2006 with the aim of imple-
menting the Helsingborg declaration for stroke care
of 2006 [20]. One of the targets of this European
stroke consensus conference was the organization of na-
tional registries to be used for improvement of stroke care.
In the Netherlands KNSN yearly sends out surveys to all
participating hospitals inquiring about numbers of stroke
patients, patient characteristics, average thrombolysis rates
and average DNT [21]. Average thrombolysis rates and
DNT were based on individual stroke registries of partici-
pating hospitals. In the first survey data on the year 2005
were asked retrospectively. From 2005 to 2008 data was
collected at stroke service level which sometimes com-
prised multiple hospitals. Information of 11 (in 2005 and
2006) and 18 (in 2007) hospitals was aggregated. From
2008 registration continued on individual hospital level.
Reported numbers are yearly averages at hospital level. All
participating hospitals receive a yearly report containing
their benchmark data in comparison with national aver-
ages. Participating hospitals have a local cooperation with
rehabilitation facilities, nursing care and home nursing
care, more or less consolidated in a formal local stroke
service. Hospitals included were urban and rural as well as
academic and non-academic hospitals. Since KNSN
started in 2006, there has been a steady increase in the
number of participating hospitals.
Definitions
The available data were on hospital level and included
total number of stroke admissions, number of admis-
sions for ischaemic stroke, mean age, and gender. Infor-
mation on thrombolysis included the number of
ischaemic stroke admissions with IVT and mean DNT.
Hospitals were categorized as academic hospitals,
non-academic referral centers (non-academic hospitals
with local function as referral center) or community
hospitals (hospital with purely local function).
Statistical analysis
We calculated the total number of stroke admissions
and admissions for ischaemic stroke per year by summa-
tion of these numbers for all participating hospitals. Per
hospital we calculated ischaemic stroke rate as number
of admissions with ischaemic stroke divided by the total
number of stroke admissions, and thrombolysis rate as
number of admissions with IVT divided by total number
of admissions for ischaemic stroke. Mean age and per-
centage males were calculated by using mean age and
percentage males per hospital weighed by total number
of stroke admissions per hospital. Overall thrombolysis
rate was calculated using the thrombolysis rate per hos-
pital weighed by the number of admissions with ischae-
mic stroke. Because of a stabilisation of the thrombolysis
rate between 2010 and 2012 we performed a sensitivity
analysis by excluding the seven hospitals who entered
the registry in 2011. Mean DNT was calculated by aver-
age DNT per hospital weighed by number of admissions
with IVT. To exclude the possibility that trends in IVT
were mainly caused by a change in participating hospi-
tals after the year of 2008 we performed a sensitivity
analysis in which we excluded all hospitals who partici-
pated in 2008 in the year of 2011 and compared mean
DNTs. We calculated means and interquartile ranges
(IQR) at hospital level for volume, mean age, percentage
male, thrombolysis rates and DNT over the years 2005
until 2012.
For analysis of the relationship between volume,
thrombolysis rates and mean DNT we used data from
2012 since it included the highest number of participat-
ing hospitals and patients. Correlations between volume
of stroke admissions, mean age, gender and type of
hospital and thrombolysis rate and mean DNT were de-
scribed with Pearson correlation coefficients (r). The dif-
ferences between academic, non-academic referral
centers and community hospitals in thrombolysis rates
were tested using chi square statistics. The differences in
type of hospital and DNT were tested with one-way
ANOVA test. With multivariable linear regression we
assessed whether volume of stroke admissions, mean
age, gender and type of hospital were independent pre-
dictors of thrombolysis rate and mean DNT. Because of
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a low number of academic hospitals we combined aca-
demic and non-academic referral hospitals. All analyses
were conducted using SPSS Version 20. Graphs were




Participation in the KNSN registry increased from 19
hospitals in 2005 to 65 in 2012, i.e., the majority of all
86 Dutch hospitals. Of these 65 hospitals there were 4
academic hospitals, 23 non-academic referral hospitals
and 38 community hospitals. In total we included
121.887 stroke admissions, ranging from 7.393 in 2005
to 24.067 in 2012. Of all admission 103,809 (85.2 %)
were ischaemic strokes of which 12,258 (11.8 %) were
thrombolysed. Table 1 presents the main characteris-
tics of all included stroke admissions. Based on the
data for the year 2012, there was limited variation in
mean age and gender between the hospitals (IQR
mean age = 71.0–73.0, IQR percentage males = 48.4–52.6).
Volume varied substantially (IQR = 234–463 admissions
per year). Also thrombolysis rate and DNT varied largely
between the hospitals. (IQR thrombolysis rate = 12.1–17.3,
IQR DNT = 38.0–47.0).
Trends in IVT rates and DNT
National thrombolysis rate increased from 6.4 % [95 %
confidence interval (CI), 6.2–6.5 %] in 2005 to 14.6 %
[95 % CI 14.5–14.6 %] in 2012 (Fig. 1). In 2011 there
was a stabilisation of the thrombolysis rate. Mean DNT
decreased from 72.2 min [95 % CI 71.4–74.0] in 2005 to
41.4 min [95 % CI 41.1–41.6] in 2012.
Relationships between volume of stroke admissions, IVT
rate and DNT
We found no correlation between higher stroke volume
and higher thrombolysis rates (Fig. 2a: R2 = 0.001, p =
0.808), and a weak but significant correlation suggesting
that higher stroke volume centres had lower DNT
(Fig. 2b: R2 = 0.08, p = 0.027). We found no correlation
between mean age (r = −.037 and r = 0.019) or gender
(r = 0.158 and r = −.008) and mean thrombolysis rate
or mean DNT respectively. Mean thrombolysis rates
higher in academic hospitals (16.7 %) compared to non-
academic referral centers (15.4 %) and community
hospitals (14.0 %) but the difference was not signifi-
cant (p = 0.251). Mean DNT was 39.6 min for aca-
demic hospitals, 39.3 min in non-academic referral
centers and 45.1 min in community hospitals (p = 0.005).
After adjusting for mean age, gender and type of hos-
pital, total stroke volume was a not significant independ-
ent predictor for thrombolysis rate (Table 2, p = 0.243,
Beta = −.224) nor for mean DNT (Table 3, p = 0.979,
Beta = 0.005). Type of hospital was no independent pre-
dictor of thrombolysis rate or for mean DNT.
Discussion
In this study we aimed to assess the trends in national
thrombolysis rates and door-to-needle times in the
Netherlands between 2005–2012 and the relationships
between stroke patient volume per hospital, thromboly-
sis rates and door-to-needle time (DNT). We found that
thrombolysis rates strongly increased throughout the
years while DNT decreased. Hospital volume was no in-
dependent predictor of thrombolysis rate nor of DNT.
Trends in thrombolysis rates and DNT
We observed an increase of national IVT rates from
6.4 % in 2005 to 14.6 % in 2012 in Dutch hospitals. This
increase corresponds to gradually increasing thromboly-
sis rates in other western countries and regions [5–9]. In
many countries campaigns have tried to improve quality
of stroke care including thrombolysis rates by adapting
guidelines for acute stroke care, improve logistic pro-
cesses within hospitals, organization of regional referral
systems, telestroke and improvement of the public
awareness for stroke [22–24]. The increased thromb-
olysis rates suggest that these measures altogether
were effective. That the routines within hospitals
similarly have improved, is reflected in decreased
DNT, from 72.7 min in 2005 to 41.4 min in 2012.
None of the trends were caused by the entrance of
new hospitals over the years. A sensitivity analysis
Table 1 Characteristics of included stroke admissions
Year 2005 2006 2007 2008 2009 2010 2011 2012
Hospitals (N) 19a 19a 28 42 44 55 63 65
Stroke admissions (N) 7393 7545 11,323 17,698 14,074 17,993 21,794 24,067
Ischemic strokes (N) 6117 6278 9585 14,780 11,916 15,473 18,889 20,771
Rate of ischemic stroke % (SD) 82.7(5.4) 83.2 (7.9) 84.7(3.4) 83.5(4.7) 84.7(5.4) 86.0(3.8) 86.7(3.8) 86.3(4.0)
Mean age (SD) 71.6(1.6) 71.5(1.5) 72.1(1.4) 72.4(2.0) 71.3(1.9) 71.7(1.7) 72.0(1.7) 71.6 (2.1)
Gender male % (SD) 49.7(2.9) 50.5(3.6) 50.6(2.2) 50.1(3.7) 51.1(4.9) 49.8(3.8) 50.5(4.6) 50.9(3.3)
aFrom 2005 to 2008 data was collected at stroke service level which sometimes comprised multiple hospitals. Information of 11 (in 2005 and 2006) and 18 (in
2007) hospitals was aggregated
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with exclusion of the seven hospitals entering the
registry in 2011 led to the same difference in results,
as well as excluding a subgroup of all 31 hospitals
participating both in 2008 and 2012.
There was a stabilisation of IVT utilization between
2010 and 2012. Patient characteristics (mean age, gen-
der, stroke type) remained stable over all of the years
and as the trend in decreasing DNT flattened as well,
it is possible that the current thromobolysis rates and
DNT reflect the maximum possible on a national
scale, without further interventions. However, thromb-
olysis rates are not optimal [3] and may increase. It is
likely that further improvements should be sought in
fighting pre-hospital delays, i.e., awareness in the gen-
eral public and emergency services.
Role of volume of stroke admissions
Total volume of stroke admissions per stroke service
was not an independent predictor of mean thrombolysis
rate nor of mean DNT. For the year of 2012 we also
found no significant relationship between volume of
stroke admissions and mean thrombolysis rates or mean
DNT, when corrected for age, gender and type of hos-
pital. There was a trend, towards higher thrombolysis
rates in larger centers. When looking at the relationship
between volume and DNT there seems to be a weak but
significant relationship. Significance disappears when
correction is used for age, gender and type of hospital.
Interestingly, academic centers had higher thrombolysis
rates, and lower DNTs together with non-academic re-
ferral centers, as compared to regional hospitals. So,
even though there is a trend suggesting that larger vol-
umes account for better results, this by no means
reaches statistical significance, but organisational issues
play a role in these process measures. This finding is in
line with many previous studies showing no relationship
between volume and processes or outcomes [16, 17, 25].
In contrast, there have been studies that demonstrated a
positive relationship [26–28]. In general, these studies
still lack to identify underlying reasons for higher
thrombolysis rates and faster DNT in high volume hos-
pitals. Other factors that might influence “in hospital”
delay include transport between the emergency depart-
ment to the CT scan laboratory or stroke department
[29]. One study found high volume hospitals to have
fewer delays between arrival and brain scanning [28].
Waiting for laboratory results, especially in patient using
anticoagulants, has been reported as a delaying factor
[30]. Physicians are more cautious in using thrombolytic
Fig. 2 Overview of thrombolysis rates and door-to-needle time per hospital in 2012. Scatterplots showing the thrombolysis rate and door-to-
needle time (DNT) by number of stroke admissions per hospital in 2012. Each dot represents the mean thrombolysis rate (a) or mean DNT (b)
per hospital. The line represents the linear regression line with R2 = 0.001 and p = 0.808 (a) and R2 = 0.08 and p = 0.027 (b)
Fig. 1 The black line represents the mean thrombolysis rate per year.
The grey line represents the mean door-to-needle time per year
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therapy in elderly patients [25] patients with mild symp-
toms, or patients suffering from posterior circulation
stroke [30]. Several international studies suggest that
thrombolysis in early arriving patients is due to be delayed
by the thought that there is enough sufficient time before
the time window ends [25, 30]. The found differences be-
tween studies from different western countries is most
likely due to different health care systems [25, 28].
Most studies on the influence of stroke admission vol-
ume on outcomes of stroke care so far used threshold
values in their statistical analysis [13–17]. Generally,
equal groups of high, medium and low hospitals are cre-
ated. The cut-off values that are implied by this method
have a direct influence on the conclusions [16, 18, 19].
Besides this statistical flaw in using thresholds, they are
clinically implausible as no sudden large improvement is
expected when a hospital treats one patient more. There
is no indication that one optimal threshold actually ex-
ists [19]. To reliably assess the relationship between vol-
ume and outcome, we chose to analyse volume on a
continuous scale.
Strengths and limitations
Our study has several strengths. First of all we used
information on a large number of admissions, cover-
ing 65 hospitals in the year 2012, a majority of all
stroke services in the Netherlands. This study was
done nationwide and included academic, large non-
academic and community hospitals. Most studies on
the effect of patient volume in stroke care so far fo-
cused exclusively on mortality rate as an outcome,
without looking at potential mediating factors be-
tween volume and outcome. In this study we aimed
at the relationship between stroke patient volume,
thrombolysis rates and DNT, thereby looking at pos-
sible underlying mechanisms through which higher
volume may cause better outcomes.
There are some potential limitations to our analysis.
Our data result from a yearly voluntary survey and par-
ticipating stroke services are self-selected. Participating
hospitals may have more focus on quality improvement
in stroke care than non-participating centers, limiting
the generalizability of our results. Mean thrombolysis
rates and DNT of non-participating hospitals may have
improved less than our national averages. For the first
three years information was collected on stroke services
level. In some areas a stroke service comprised multiple
hospitals making it difficult to compare hospital level in-
formation between 2005–2007 and the years after. Only
information on hospital level was available, so we were
not able to perform corrections for individual patient
characteristics. This may have introduced bias when as-
sociations at the group level do not represent associa-
tions at the individual level.
Additionally, we did not have information on stroke se-
verity, which is an important case-mix factor in stroke.
Limited data on post-admission functional status with
Barthel index (not presented here) do not point to large dif-
ferences in stroke severity. Data on patient outcome (e.g.,
mortality) were insufficiently available in this study and
therefore could not be used. A final limitation is that we
present data on hospital admissions, it is possible that one
patient had more than one admission in the same year.
Implications
In view of a current debate whether norms merely based
on patient numbers should be used for selecting stroke
centers, we found no clear relationship between volume
and intravenous thrombolysis rate and DNT. The current
literature does not provide evidence for a volume
threshold-based policy. Future extension of the current
stroke registration to individual patient data will help us to
further examine underlying processes in stroke care that
potentially mediate a relationship between volume and out-
come. It should be emphasized that our conclusion only
concerns the relationship between volume and outcome in
intravenous thrombolysis. In view of the proven effective-
ness of mechanical thrombectomy, and hence the increas-
ing use of this treatment, the use of this treatment will
increasingly determine the quality of stroke care. Because
mechanical thrombectomy is technically a more compli-
cated procedure it is possible that in this treatment volume
Table 2 Linear regression analysis of possible independent





Academic (reference) 0 0
Non-academic referral 0,409 0,418
Community 0,083 0,87
Total stroke volume −0,224 0,243
Table 3 Linear regression analysis of possible independent





Academic (reference) 0 0
Non-academic referral −0,281 0,562
Community 0,135 0,785
Total stroke volume
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actually does have an influence on the ultimate outcome.
A better understanding of the mechanisms explaining the
debated positive relationship between volume and outcome
in stroke might help us to improve acute stroke care more
than use of single threshold values can.
Conclusion
Intravenous thrombolysis rates in the Netherlands more
than doubled between 2005 and 2012 from 6.4 % to
14.6 %, and there was a large decline in mean DNT. When
corrected for age, gender and type of hospital, we found
no evidence for a relationship between stroke admission
volume per hospital and mean thrombolysis rate and
door-to-needle-time. Thus, our data do not support a
solely volume based policy of selection of stroke centres
for thrombolytic therapy. Yet organisational issues are
relevant. Future extension of our registration to individual
patient data will help further improvement of stroke care.
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